Free Trial

Surgery Partners (NASDAQ:SGRY) Stock Price Up 4.9% - What's Next?

Surgery Partners logo with Medical background

Key Points

  • Surgery Partners' shares rose by 4.9% reaching a trading high of $22.37, despite a decrease in trading volume compared to the average sessions.
  • Analysts maintain a favorable outlook on the company, with a consensus target price of $33.33 and a mix of buy, hold, and sell ratings.
  • In the latest earnings report, Surgery Partners reported revenue of $776 million for the quarter, showing an 8.2% year-over-year increase, although it missed analysts' expectations for EPS.
  • MarketBeat previews top five stocks to own in September.

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) rose 4.9% on Monday . The stock traded as high as $22.37 and last traded at $22.30. Approximately 417,545 shares changed hands during trading, a decline of 69% from the average daily volume of 1,355,952 shares. The stock had previously closed at $21.26.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on SGRY shares. Bank of America started coverage on Surgery Partners in a report on Monday. They issued a "buy" rating and a $28.00 price target on the stock. Barclays reduced their price objective on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 27th. Finally, Benchmark restated a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Monday, April 21st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $33.33.

View Our Latest Stock Report on Surgery Partners

Surgery Partners Stock Down 3.1%

The firm has a market cap of $2.73 billion, a price-to-earnings ratio of -13.91 and a beta of 1.90. The firm's fifty day moving average is $22.22 and its two-hundred day moving average is $22.85. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.89 and a quick ratio of 1.73.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The firm had revenue of $776.00 million for the quarter, compared to analyst estimates of $777.77 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 6.10%. Surgery Partners's revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.10 earnings per share. On average, sell-side analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Institutional Trading of Surgery Partners

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Sei Investments Co. grew its position in Surgery Partners by 13.9% in the fourth quarter. Sei Investments Co. now owns 43,666 shares of the company's stock worth $924,000 after buying an additional 5,333 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of Surgery Partners during the 4th quarter worth $273,000. LPL Financial LLC grew its holdings in shares of Surgery Partners by 22.4% in the 4th quarter. LPL Financial LLC now owns 16,749 shares of the company's stock worth $355,000 after acquiring an additional 3,062 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Surgery Partners by 2.3% during the fourth quarter. Vanguard Group Inc. now owns 7,618,404 shares of the company's stock worth $161,282,000 after purchasing an additional 172,271 shares during the period. Finally, Norges Bank acquired a new stake in shares of Surgery Partners during the fourth quarter worth $15,796,000.

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Read More

Should You Invest $1,000 in Surgery Partners Right Now?

Before you consider Surgery Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.

While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines